Autoimmune Movement Disorders: a Clinical and Laboratory Approach

Curr Neurol Neurosci Rep. 2017 Jan;17(1):4. doi: 10.1007/s11910-017-0709-2.

Abstract

Autoimmune movement disorders are caused by an aberrant immune response to neural self-antigens. These disorders may be paraneoplastic, parainfectious, or (most commonly) idiopathic. The neurological presentations are diverse, and sometimes multifocal. Movement disorders can occur as part of the spectrum with phenotypes including chorea, myoclonus, ataxia, CNS hyperexcitability (including stiff-person syndrome), dystonia, and parkinsonism. Symptoms are subacute in onset and may have a fluctuating course. The best characterized disorders are unified by neural autoantibodies identified in serum or cerebrospinal fluid. The antibody specificity may predict the association with cancer and the response to immunotherapy. In this article, we review autoimmune-mediated movement disorders, associated cancers, diagnosis, and treatment.

Keywords: Autoimmunity; Immunotherapy; Movement disorders; Neuronal autoantibodies; Paraneoplastic.

Publication types

  • Review

MeSH terms

  • Autoantibodies / immunology
  • Autoantigens / immunology
  • Autoimmune Diseases / immunology*
  • Autoimmune Diseases / therapy
  • Humans
  • Immunologic Tests
  • Immunotherapy
  • Movement Disorders / diagnosis
  • Movement Disorders / immunology*
  • Movement Disorders / therapy

Substances

  • Autoantibodies
  • Autoantigens